| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immunovant, Inc. | Chief Medical Officer | Common Stock | 228K | $2.96M | $12.99 | Apr 9, 2025 | Direct |
| Immunovant, Inc. | Chief Medical Officer | Stock Option (right to buy) | 143K | Apr 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Apr 9, 2025 | 1 | -$80.1K | 4 | Apr 11, 2025 | Chief Medical Officer |
| IMVT | Immunovant, Inc. | Apr 1, 2025 | 2 | $0 | 4 | Apr 3, 2025 | Chief Medical Officer |
| IMVT | Immunovant, Inc. | Jan 22, 2025 | 1 | -$62.7K | 4 | Jan 24, 2025 | Chief Medical Officer |
| IMVT | Immunovant, Inc. | Oct 23, 2024 | 1 | -$94.2K | 4 | Oct 25, 2024 | Chief Medical Officer |
| IMVT | Immunovant, Inc. | Jul 24, 2024 | 1 | -$95.9K | 4 | Jul 26, 2024 | Chief Medical Officer |
| IMVT | Immunovant, Inc. | Apr 24, 2024 | 1 | -$94.2K | 4 | Apr 26, 2024 | Chief Medical Officer |
| IMVT | Immunovant, Inc. | Apr 2, 2024 | 2 | $0 | 4 | Apr 4, 2024 | Chief Medical Officer |
| IMVT | Immunovant, Inc. | Jan 26, 2024 | 2 | -$383K | 4 | Jan 29, 2024 | Chief Medical Officer |
| IMVT | Immunovant, Inc. | Jan 16, 2024 | 0 | $0 | 3 | Jan 16, 2024 | Chief Medical Officer* |